Cyclopharm’s USFDA Technegas Clinical Trial – Patient Enrolment Underway

Cyclopharm is pleased to announce that the first two patients have been enrolled today in the Company’s United States Food & Drug Administration (USFDA) Phase 3 clinical trial for its proprietary lung imaging technology, Technegas.